Adage Capital Partners
ANAB icon

Adage Capital Partners’s AnaptysBio ANAB Stock Holding History

Adage Capital Partners’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,695,922
Closed -$94.3M – 715
2019
Q3 		$94.3M Buy
2,695,922
+130,000
+5% +$6.19M 0.23% 108
2019
Q2 		$145M Sell
2,565,922
-107,862
-4% -$7.77M 0.36% 64
2019
Q1 		$195M Buy
2,673,784
+378,784
+17% +$26.1M 0.49% 49
2018
Q4 		$146M Buy
2,295,000
+994,685
+76% +$74M 0.41% 59
2018
Q3 		$130M Sell
1,300,315
-248,929
-16% -$20.7M 0.29% 95
2018
Q2 		$110M Buy
1,549,244
+171,744
+12% +$14.4M 0.25% 102
2018
Q1 		$143M Buy
1,377,500
+127,500
+10% +$14.4M 0.33% 77
2017
Q4 		$126M Buy
1,250,000
+31,014
+3% +$2.28M 0.28% 91
2017
Q3 		$42.6M Buy
1,218,986
+687,310
+129% +$18.5M 0.1% 251
2017
Q2 		$12.7M Buy
531,676
+286,676
+117% +$7.2M 0.03% 516
2017
Q1 		$6.8M Buy
+245,000
New +$5.71M 0.02% 586

Other funds holding ANAB

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Adage Capital Partners's ANAB Position: Q4 2019 in Review

Adage Capital Partners sold out of AnaptysBio (ANAB) in Q4 2019, closing a stake of 2,695,922 shares — an estimated $94.3M sold.

Adage Capital Partners first reported a position in ANAB in Q1 2017 and held it in 11 quarters. The position peaked at $195M in Q1 2019. 121 funds tracked by Wall St. Rank hold ANAB as of Q4 2019.

  • Adage Capital Partners reported no remaining AnaptysBio position as of Q4 2019 after selling out during the quarter.
  • Adage Capital Partners sold 2,695,922 AnaptysBio shares in Q4 2019, an estimated $94.3M.
  • Adage Capital Partners first reported a position in AnaptysBio in Q1 2017 and held it in 11 quarters.
  • Adage Capital Partners's AnaptysBio position peaked at $195M in Q1 2019.
  • 121 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2019.

Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.